FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

28919311000001105: Haloperidol 5mg tablets (Crescent Pharma Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Apr 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
90788701000001115 Haloperidol 5mg tablets (Crescent Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
90788801000001112 Haloperidol 5mg tablets (Crescent Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Haloperidol 5mg tablets (Crescent Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Haloperidol 5mg tablets (Crescent Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Haloperidol 5mg tablets (Crescent Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Haloperidol 5mg tablets (Crescent Pharma Ltd) Is a Product containing precisely haloperidol 5 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Haloperidol 5mg tablets (Crescent Pharma Ltd) Has active ingredient Haloperidol false Inferred relationship Existential restriction modifier
Haloperidol 5mg tablets (Crescent Pharma Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Haloperidol 5mg tablets (Crescent Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Haloperidol 5mg tablets (Crescent Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Haloperidol 5mg tablets (Crescent Pharma Ltd) Has specific active ingredient Haloperidol true Inferred relationship Existential restriction modifier
Haloperidol 5mg tablets (Crescent Pharma Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Haloperidol 5mg tablets (Crescent Pharma Ltd) Has excipient Tartrazine stain false Inferred relationship Existential restriction modifier
Haloperidol 5mg tablets (Crescent Pharma Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Haloperidol 5mg tablets (Crescent Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Haloperidol 5mg tablets (Crescent Pharma Ltd) 28 tablet 2 x 14 tablets Has AMP True Haloperidol 5mg tablets (Crescent Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start